Avaliacao da atividade da nova cefalosporina de quarta geracao cefpiroma contra amostras clinicas isoladas em unidades de terapia intensiva e unidades de oncoematologia de varios hospitais brasileiros

Objective: To evaluate the in vitro activity of the fourth-generation cephalosporin cefpirome in comparison to that of ceftazidime, ceftriaxone, cefotaxime and imipenem in a multicenter study involving nine hospitals from six cities (four states). Material and methods: A total of 804 isolates from patients hospitalized in either intensive care units or Oncology/Hematology units was evaluated. The isolates were collected between June and November of 1995, i.e. before cefpirome became commercially available in Brazil, and susceptibility tested by broth microdilution following the NCCLS procedures. All isolates resistant to cefpirome were retested by B-test. Results: Against Enterobacteriaceae (n = 344), cefpirome demonstrated an activity 2 to 32-fold higher than that of the third-generation cephalosporins (TGCs) and similar to that of imipenem. The percentages of Enterobacteriaceae susceptible were: 88%, 69% and 96% for cefpirome, TGCs and imipenem, respectively, The cefpirome spectrum were greater or equal to that of imipenem against Citrobacter freundii, Enterobacter aerogenes, Morganellao morganii and Serratia marcescens. Against Acinetobacter sp. (n = 77), cefpirome was slightly more active than ceftazidime; however, the percentages of isolates resistant to these compounds were high (84% and 88%, respectively). The activities of cefpirome, ceftazidime and imipenem were very similar against P. aeruginosa isolates (n = 128), with MIC50 (μg/ml) percent susceptible of 8/59%, 8/62% and 4/62% respectively, Against aerobic gram-positive bacteria, the cefpirome activity was 4 to 16-fold higher than that of TGCs but 2 to 8-fold lower than that of imipenem. Conclusion: The results of our study suggest that, in Brazil, cefpirome has a spectrum of activity which is higher than that of the TGCs against aerobic gram-negative (Enterobacteriaceae and non-Enterobacteriaceae) and gram-positive bacteria and similar to that of imipenem against some Enterobacteriaceae species and P. aeruginosa.

Soroprevalência de HTLV/II, e fatores de risco, em gestantes do município de Botucatu atendidas em unidades básicas de saúde

Pós-graduação em Doenças Tropicais - FMB

A representação gráfica das unidades de paisagem no zoneamento ambiental: um estudo de caso no município de Ourinhos SP

Pós-graduação em Geografia - IGCE

Qualidade de vida no envelhecimento: situação dos idosos assistidos em unidades de saúde da família do município do interior paulista

Pós-graduação em Enfermagem (mestrado profissional) - FMB

Uma abordagem didático-pedagógica do cálculo diferencial e integral I na formação de professores de matemática

Pós-graduação em Educação Matemática - IGCE

Agrupamentos de amostras circulares em função das unidades de solo

The objective of the study was to analyze the features of the relief through the variables: maximum altitude (HM); mean altitude (Hmd); minimum altitude (Hm); altitude range (H); average slope length (CVm); minimum length of run-off (Cd) and average steepness of circular samples (I) of the Capivara River Watershed – Botucatu (SP). A total of 4 circular samples were obtained per unit of soil (Quartzipsamment alfisol oxisol - RQ, Udox - LVA and Udorthent - RL). Multivariable analysis and aerial color photographs of 2000, Brazilian Chart and Soil Chart of Botucatu city-SP were used for data analyses. Soil differentiation was performed using the Student-t Test for analyzes of orthogonal contrasts among means of the three soils and analysis of groupings and major components. The grouping analysis of the variables of relief differentiated 75% of LVA and 100% of RL and RQ soil circular samples. The most efficient parameters of relief for differentiation of soils according to their order of importance were as follows: HM, Hm, Hmd and H.

Fatores de risco relacionados à perda de produtividade laboral e aumento dos custos ambulatoriais de pacientes atendidos por unidades básicas de saúde

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)